Internationally Recognized Leader in PRP, Regenerative Injection Technique and Prolotherapy
Dr Weglein is Certified in Prolotherapy/ Regenerative Injection Technique from the America Academy of Orthopedic Medicine and Oxygen Therapy Certified under Dr Schallenberger.
Helping your body heal itself, Dr Weglein has treated thousands of Bone on Bone Arthritis patients
Dr Weglein, (Registered Physician Ultrasonography), Uses ultrasound guidance to place customized doses of your body’s cells precisely into the area of need
Home » Blog » Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes
Purpose Clinical studies in diabetic patients have demonstrated that there is a high incidence of complications in distal tibia and ankle fracture treatments. One strategy to mitigate issues with wound healing and infection in diabetic patients is to use a percutaneous technique in which autologous, bone marrow-derived, concentrated cells are injected at the site of non-unions